COVID-19 and management of neuroimmunological disorders

Nature Reviews Neurology, Published online: 22 May 2020; doi:10.1038/s41582-020-0368-9The importance of reported neurological manifestations of coronavirus disease 2019 (COVID-19) is still unclear. Nevertheless, an immediate and ongoing neurological challenge posed by the COVID-19 pandemic is the management of patients who are undergoing immunotherapy for existing neuroimmunological disease.
Source: Nature Reviews Neurology - Category: Neurology Authors: Source Type: research